by Sarah Avery, Duke University Graphical abstract. Credit: Cell (2024). DOI: 10.1016/j.cell.2023.12.002The path to a successful HIV vaccine depends on a critical first step—activating specific immune cells that induce broadly neutralizing antibodies. Reporting Jan. 4 in the journal Cell, a research team led by the Duke Human Vaccine Institute has achieved that requisite initial step in...
